{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:46:11Z","timestamp":1785793571572,"version":"3.56.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ijbiomac.2023.126002","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T11:54:26Z","timestamp":1690372466000},"page":"126002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Targeted vaccine development against Bilophila wadsworthia to curb colon diseases: A multiepitope approach based on reverse vaccinology and computational analysis"],"prefix":"10.1016","volume":"250","author":[{"given":"Sara","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahkaar","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Waqas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Azam","family":"Kakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohail","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.126002_bb0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fphys.2016.00156","article-title":"Emerging roles of hydrogen sulfide in inflammatory and neoplastic colonic diseases","volume":"7","author":"Guo","year":"2016","journal-title":"Front. Physiol."},{"issue":"4-6","key":"10.1016\/j.ijbiomac.2023.126002_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/ars.2021.0004","article-title":"Effects of hydrogen sulfide on the microbiome: from toxicity to therapy","volume":"36","author":"Buret","year":"2022","journal-title":"Antioxid. Redox Signal."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.126002_bb0015","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.chembiol.2021.03.001","article-title":"Molecular basis of CS bond cleavage in the glycyl radical enzyme isethionate sulfite-lyase","volume":"28","author":"Dawson","year":"2021","journal-title":"Cell Chem. Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126002_bb0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/em.20546","article-title":"DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells","volume":"51","author":"Attene-Ramos","year":"2010","journal-title":"Environ. Mol. Mutagen."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126002_bb0025","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.molmed.2016.01.002","article-title":"Sulfide as a mucus barrier-breaker in inflammatory bowel disease?","volume":"22","author":"Ijssennagger","year":"2016","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126002_bb0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1574-6941.2002.tb00942.x","article-title":"Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases","volume":"40","author":"Loubinoux","year":"2002","journal-title":"FEMS Microbiol. Ecol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126002_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/gut.46.1.64","article-title":"The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis","volume":"46","author":"Pitcher","year":"2000","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.126002_bb0040","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1089\/ars.2013.5312","article-title":"Hydrogen sulfide signaling in the gastrointestinal tract","volume":"20","author":"Linden","year":"2014","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0045","series-title":"The narrative construction of reality: an interview with Stuart Hall.-Reprinted from a transcript of an interview by John O'Hara on the ABC programme'Double Take', 5 May 1983, Southern Review (Adelaide)","first-page":"3","volume":"17(1)","author":"Hall","year":"1984"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126002_bb0050","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/cmi.2017.92","article-title":"Multi-epitope vaccines: a promising strategy against tumors and viral infections","volume":"15","author":"Zhang","year":"2018","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0055","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s00253-013-5408-6","article-title":"Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB\/c mice model","volume":"98","author":"Guo","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.126002_bb0060","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1158\/1078-0432.CCR-13-0002","article-title":"A randomized phase II trial of multiepitope vaccination with melanoma peptides for cytotoxic T cells and helper T cells for patients with metastatic melanoma (E1602) multipeptide vaccine for advanced melanoma","volume":"19","author":"Slingluff","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"30","key":"10.1016\/j.ijbiomac.2023.126002_bb0065","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1016\/S0264-410X(01)00111-6","article-title":"A phase I clinical trial of a multi-epitope polypeptide TAB9 combined with Montanide ISA 720 adjuvant in non-HIV-1 infected human volunteers","volume":"19","author":"Toledo","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126002_bb0070","doi-asserted-by":"crossref","first-page":"9044","DOI":"10.1038\/s41598-018-26689-7","article-title":"Subtractive proteomics to identify novel drug targets and reverse vaccinology for the development of chimeric vaccine against Acinetobacter baumannii","volume":"8","author":"Solanki","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0075","doi-asserted-by":"crossref","DOI":"10.3410\/B2-36","article-title":"Bacterial surface proteins and vaccines","volume":"2","author":"Grandi","year":"2010","journal-title":"F1000 Biol. Rep."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.meegid.2015.03.027","article-title":"Identification of putative vaccine candidates against Helicobacter pylori exploiting exoproteome and secretome: a reverse vaccinology based approach","volume":"32","author":"Naz","year":"2015","journal-title":"Infect. Genet. Evol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126002_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052773","article-title":"Exoproteome and secretome derived broad spectrum novel drug and vaccine candidates in Vibrio cholerae targeted by Piper betel derived compounds","volume":"8","author":"Barh","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126002_bb0090","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3201\/eid0503.990310","article-title":"Adhesins as targets for vaccine development","volume":"5","author":"Wizemann","year":"1999","journal-title":"Emerg. Infect. Dis."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.126002_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000796","article-title":"NetMHCpan, a method for quantitative predictions of peptide binding to any HLA-A and-B locus protein of known sequence","volume":"2","author":"Nielsen","year":"2007","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126002_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1000107","article-title":"Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan","volume":"4","author":"Nielsen","year":"2008","journal-title":"PLoS Comput. Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126002_bb0105","first-page":"1","article-title":"An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126002_bb0110","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/vaccines2030515","article-title":"Peptide vaccine: progress and challenges","volume":"2","author":"Li","year":"2014","journal-title":"Vaccines"},{"issue":"47","key":"10.1016\/j.ijbiomac.2023.126002_bb0115","doi-asserted-by":"crossref","first-page":"32043","DOI":"10.1021\/acsomega.1c04817","article-title":"Designing of a multi-epitope vaccine against the structural proteins of marburg virus exploiting the immunoinformatics approach","volume":"6","author":"Sami","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0120","series-title":"Molecular Operating Environment (MOE), Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite 910, Montreal, QC, Canada","author":"C.C.G. ULC","year":"2022"},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0125","series-title":"Blender Foundations: The Essential Guide to Learning Blender 2.5","author":"Hess","year":"2013"},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0130","series-title":"Amber2022","author":"Case","year":"2022"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.126002_bb0135","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1063\/1.2820230","article-title":"Numerical recipes: the art of scientific computing","volume":"40","author":"Press","year":"1987","journal-title":"Phys. Today"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.126002_bb0140","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1021\/ct800573m","article-title":"Bad seeds sprout perilous dynamics: stochastic thermostat induced trajectory synchronization in biomolecules","volume":"5","author":"Sindhikara","year":"2009","journal-title":"J. Chem. Theory Comput."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.126002_bb0145","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","article-title":"A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations","volume":"22","author":"Kr\u00e4utler","year":"2001","journal-title":"J. Comput. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126002_bb0150","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126002_bb0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations","volume":"51","author":"Hou","year":"2011","journal-title":"J. Chem. Inf. Model."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.126002_bb0160","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1039\/C6MB00521G","article-title":"Allosteric mechanism of cyclopropylindolobenzazepine inhibitors for HCV NS5B RdRp via dynamic correlation network analysis","volume":"12","author":"ur Rahman","year":"2016","journal-title":"Mol. BioSyst."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.126002_bb0165","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.mib.2011.07.002","article-title":"The IRG protein-based resistance mechanism in mice and its relation to virulence in Toxoplasma gondii","volume":"14","author":"Howard","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.126002_bb0170","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S1567-5769(03)00016-X","article-title":"Old and new vaccine approaches","volume":"3","author":"Arnon","year":"2003","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.126002_bb0175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/intimm\/dxw015","article-title":"Vaccine adjuvants as potential cancer immunotherapeutics","volume":"28","author":"Temizoz","year":"2016","journal-title":"Int. Immunol."},{"issue":"9\u201310","key":"10.1016\/j.ijbiomac.2023.126002_bb0180","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.drudis.2007.03.010","article-title":"Harnessing bioinformatics to discover new vaccines","volume":"12","author":"Davies","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0185","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.micpath.2018.09.042","article-title":"Subtractive proteomics and immunoinformatics revealed novel B-cell derived T-cell epitopes against Yersinia enterocolitica: an etiological agent of Yersiniosis","volume":"125","author":"Ain","year":"2018","journal-title":"Microb. Pathog."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126002_bb0190","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0195","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.3389\/fimmu.2019.02698","article-title":"In silico design of an epitope-based vaccine ensemble for Chagas disease","volume":"10","author":"Michel-Tod\u00f3","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.126002_bb0200","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/protein\/14.8.529","article-title":"Design of the linkers which effectively separate domains of a bifunctional fusion protein","volume":"14","author":"Arai","year":"2001","journal-title":"Protein Eng."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.621706","article-title":"Immunoinformatics design of multi-epitope peptide-based vaccine against Schistosoma mansoni using transmembrane proteins as a target","volume":"12","author":"Sanches","year":"2021","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126002_bb0210","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1080\/21645515.2015.1012017","article-title":"In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations","volume":"11","author":"Yang","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.126002_bb0215","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.4049\/jimmunol.168.11.5499","article-title":"A rational strategy to design multiepitope immunogens based on multiple Th lymphocyte epitopes","volume":"168","author":"Livingston","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0220","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/1459394","article-title":"Adjuvants: classification, modus operandi, and licensing","volume":"2016","author":"Apostolico","year":"2016","journal-title":"J Immunol Res"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126002_bb0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/vaccines3030579","article-title":"Cholera toxin subunit B as adjuvant\u2013\u2013an accelerator in protective immunity and a break in autoimmunity","volume":"3","author":"Stratmann","year":"2015","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.126002_bb0230","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1128\/IAI.69.3.1528-1535.2001","article-title":"Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids","volume":"69","author":"Bowman","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0235","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.3389\/fimmu.2018.02212","article-title":"The nontoxic cholera B subunit is a potent adjuvant for intradermal DC-targeted vaccination","volume":"9","author":"Antonio-Herrera","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126002_bb0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.molimm.2015.05.008","article-title":"Evidence for TLR4 and FcR\u03b3\u2013CARD9 activation by cholera toxin B subunit and its direct bindings to TREM2 and LMIR5 receptors","volume":"66","author":"Phongsisay","year":"2015","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.126002_bb0245","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/vaccines7020034","article-title":"In silico designed ebola virus T-cell multi-epitope DNA vaccine constructions are immunogenic in mice","volume":"7","author":"Bazhan","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cimid.2020.101413","article-title":"Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice","volume":"69","author":"Foroutan","year":"2020","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0255","doi-asserted-by":"crossref","DOI":"10.1177\/1177932218755337","article-title":"Immune-informatic analysis and design of peptide vaccine from multi-epitopes against Corynebacterium pseudotuberculosis","volume":"12","author":"Droppa-Almeida","year":"2018","journal-title":"Bioinf. Biol. Insights"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.126002_bb0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12976-015-0013-2","article-title":"In silico characterization and molecular modeling of double-strand break repair protein MRE11 from Phoenix dactylifera v deglet nour","volume":"12","author":"Rekik","year":"2015","journal-title":"Theor. Biol. Med. Model."},{"key":"10.1016\/j.ijbiomac.2023.126002_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fcimb.2013.00003","article-title":"Recognition of lipid A variants by the TLR4-MD-2 receptor complex","volume":"3","author":"Maeshima","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1-6","key":"10.1016\/j.ijbiomac.2023.126002_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1699-0463.1993.tb00073.x","article-title":"Interferon-gamma and resistance to bacterial infections","volume":"101","author":"Czarniecki","year":"1993","journal-title":"Apmis"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023028970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023028970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:01:57Z","timestamp":1785790917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023028970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":54,"alternative-id":["S0141813023028970"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126002","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted vaccine development against Bilophila wadsworthia to curb colon diseases: A multiepitope approach based on reverse vaccinology and computational analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.126002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"126002"}}